October 16, 2017 –
Cost will be one of the most important factors to determine whether or not a biosimilar pegfilgrastim improves patient access to the treatment, said Leora Horn, MD, clinical director of thoracic oncology at Vanderbilt-Ingraham Cancer Center, assistant vice chancellor for faculty development at Vanderbilt University Medical Center.
October 15, 2017 –
Value-based care will start to transition from being an option to being a requirement, and better data will be needed to improve how care is delivered to patients, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.
October 14, 2017 –
Compared with the trial results of EUCLID and PEGASUS, the COMPASS trial advances the field of cardiovascular disease in combination therapies, said John Eikelboom, MD, of McMaster University.
October 13, 2017 –
As the healthcare industry tries to move away from fee-for-service, the new Scorecard being developed by Catalyst for Payment Reform will help states get a better understanding of whether or not new payment models are actually working, explained Linda Schwimmer, CEO and president of the New Jersey Health Care Quality Institute.
October 13, 2017 –
Charlie Fazio, MD, senior vice president and medical director of HealthPartners discusses the uncertainty felt by practices as the industry moves from fee-for-service to value-based care.
October 11, 2017 –
Naiyer A. Rizvi, MD, director of thoracic oncology and immunotherapeutics at Columbia University Medical Center discusses the effectiveness of PD-1 antibodies in lung cancer.
October 10, 2017 –
Getting people on board when a new electronic health record (EHR) is being implemented is one of the biggest obstacles to overcome and is important for the success of the new EHR, said Teri Kovach, RN, OCN, compliance officer and charge nurse at Salish Cancer Center.
October 09, 2017 –
Technological advances will lead to improvements in clinical trials and greater participation in trials by patients, explained Michael Kolodziej, MD, national medical director of managed care strategy at Flatiron Health.
October 08, 2017 –
Payers and other organizations can help smaller practices develop the necessary infrastructure to complete their healthcare transformation, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.
October 06, 2017 –
As the health system evolves it will become increasingly important that practices understand business, explained Tesh Khullar, senior vice president of provider solutions at Flatiron Health.